At the news
? BULLISHIMPACT 7/10 8-K filed Aug 5, 2026 at 06:05 ET
LivaNova reported Q2 2026 revenue of $390.6M (+10.8% YoY) and adjusted diluted EPS of $1.26, beating consensus estimates of $1.09 by 15.6%. The company raised full-year 2026 revenue growth guidance to 8%-9% (from 7%-8%) and adjusted EPS guidance to $4.30-$4.40 (from $4.20-$4.30), reflecting strong execution in Cardiopulmonary and Neuromodulation. A favorable Italian tax ruling generated a $95.4M discrete benefit, boosting GAAP EPS to $1.93, but the core beat and guidance raise are the primary drivers for the stock.
- Q2 2026 revenue of $390.6M (+10.8% reported, +9.8% constant-currency) beat consensus of $380.6M.
- Adjusted diluted EPS of $1.26 beat consensus of $1.09 by 15.6%.
- Full-year 2026 revenue growth guidance raised to 8%-9% constant-currency (from 7%-8%).
- Full-year 2026 adjusted EPS guidance raised to $4.30-$4.40 (from $4.20-$4.30).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access